Enzo Biochem Inc ( Enzo Biochem)

Primary tabs

Enzo Biochem's picture

Management

Contact Address

About Enzo Biochem Inc

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products systems and services that meet the ever-changing and rapidly growing needs of health care both today and into the future. Underpinning Enzo Biochem’s products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies.

Enzo Biochem press release, blog etc

Tue, 06/24/2025 - 07:17 Enzo Biochem, Inc. To be Acquired by Battery Ventures in All-Cash Transaction
Tue, 04/22/2025 - 11:15 Enzo Biochem, Inc. Announces Review of Strategic Alternatives after Receiving Multiple Inquiries Regarding a Potential Transaction
Fri, 03/28/2025 - 18:15 Enzo Biochem Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock and Transfer Trading of Shares to OTCQX
Sat, 02/03/2024 - 04:33 Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
Wed, 08/03/2022 - 13:02 Enzo Biochem Appoints Matthew Kupferberg as General Counsel
Thu, 03/31/2022 - 23:37 Enzo Biochem Adjourns Annual Meeting of Shareholders Until
Mon, 03/28/2022 - 00:03 Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
Sun, 01/02/2022 - 22:28 Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochems Board of Directors
Tue, 11/09/2021 - 13:04 ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER
Thu, 10/21/2021 - 03:09 Enzo Biochem Expands GoTestMeNow Online Portal to Provide Patients with Direct Access to Private Testing for Sexually Transmitted Infections
Mon, 10/18/2021 - 12:42 HAMID ERFANAIN NAMED CHIEF EXECUTIVE OFFICER OF ENZO BIOCHEM TO ACCELERATE EXPANSION AND COMMERCIALIZATION OF KEY DIAGNOSTIC PLATFORMS
Thu, 09/02/2021 - 18:09 ENZO BIOCHEM TO PRESENT AT THE H.C. WAINWRIGHT 23RD ANNUAL GLOBAL INVESTMENT CONFERENCE
Mon, 07/19/2021 - 22:29 ENZO BIOCHEM RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR RAPID EXTRACTION METHOD ON PROPRIETARY TEST SYSTEM FOR DETECTION OF CORONAVIRUS SARS-CoV-2
Tue, 06/15/2021 - 00:41 Enzo Biochem Announces Online Service with TrustAssure to Schedule Timely PCR Testing Required for International Travel
Wed, 04/21/2021 - 07:38 Enzos Universal AMPICOLLECT Used on GENFLEX Molecular Platform Cleared for Distribution by FDA Under Emergency Use Authorization
Thu, 03/04/2021 - 17:28 Enzo Biochem to Participate in the H.C. Wainwright Global Life Sciences Conference
Mon, 03/01/2021 - 18:08 Enzo Announces its GENFLEX Molecular Test Detects Current COVID-19 Variants
Wed, 02/03/2021 - 11:57 Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
more

InfoBox

HomePagewww.enzo.com